| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Options Exercise | $0 | +7,057 | +34% | $0.000000 | 28,077 | 04 Aug 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Options Exercise | $0 | +4,798 | +17% | $0.000000 | 32,875 | 04 Aug 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Tax liability | $922,936 | -2,777 | -8.4% | $332.35 | 30,098 | 04 Aug 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Tax liability | $627,439 | -1,888 | -6.3% | $332.33 | 28,210 | 04 Aug 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | $1,668,699 | -5,040 | -18% | $331.09 | 23,170 | 04 Aug 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | $713,344 | -2,150 | -9.3% | $331.79 | 21,020 | 04 Aug 2021 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LII | Non-qualified Stock Appreciation Right | Options Exercise | $0 | -9,785 | -100% | $0.000000* | 0 | 04 Aug 2021 | Common Stock, Par Value $0.01 Per Share | 9,785 | $92.64 | Direct | F1 |
| transaction | LII | Non-qualified Stock Appreciation Right | Options Exercise | $0 | -7,959 | -100% | $0.000000* | 0 | 04 Aug 2021 | Common Stock, Par Value $0.01 Per Share | 7,959 | $131.94 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | One third of the Stock Appreciation Rights became exercisable on 12/12/2015 and each year thereafter. The entire grant became fully exercisable on 12/12/2017. |
| F2 | One third of the Stock Appreciation Rights became exercisable on 12/11/2016 and each year thereafter. The entire grant became fully exercisable on 12/11/2018. |